Physician profile
Barbara E Pine
NPI 1265771208
$745.10
in general payments reported to CMS, 2019-2025
14 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $191 · 2022: $175 · 2023: $39.42 · 2024: $40.49 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $367.07 | 2021-2025 | Lifevest |
| Atricure, INC. | $68.27 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Janssen Pharmaceuticals, INC | $46.59 | 2021-2023 | Xarelto |
| W. L. Gore & Associates, INC. | $37.36 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Ethicon US, LLC | $34.17 | 2025 | Prolene |
| Medtronic, INC. | $30.31 | 2022 | |
| Corcym INC | $28.46 | 2022 | |
| Abbott Laboratories | $24.64 | 2022 | |
| Angiodynamics, INC. | $20.26 | 2021 | |
| Tactile Systems Technology INC | $19.45 | 2024 | Flexitouch Plus, Entre Plus |
| E.R. Squibb & Sons, L.L.C. | $17.69 | 2021 | |
| Baxter Healthcare | $17.51 | 2022 | |
| Lemaitre Vascular, INC. | $17.26 | 2025 | Hydro Lemaitre Valvulotome |
| Teleflex LLC | $16.06 | 2025 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Pine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.